Organization | Hospital Lucerne

Hospital Lucerne Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

1992

NCT00382421

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2019

Timeline

NOW

Now

Alternative names

Cantonal Hospital of Lucerne | Department of Cardiology, Hospital Lucerne

Active Ingredients

Drugs in Other Trials (4)

acetylsalicylic acid (aspirin) (1 trial)

amlodipine (norvasc) (1 trial)

bisoprolol (zebeta) (1 trial)

Molsidomine (motazomin) (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 1
# of Trial APIs: 4